AHA files motions as 340B case returns to district court to determine remedy
Following its unanimous victory in the U.S. Supreme Court earlier this summer, AHA yesterday asked the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to immediately stop underpaying certain hospitals that participate in the 340B Drug Pricing Program and promptly repay them for the unlawful cuts since 2018 without penalizing other hospitals.
Related News Articles
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug…
Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation…